A Study to Assess TTI-0102 vs Placebo in MELAS Patients

NCT06644534 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

MELAS Syndrome
Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)

Interventions

DRUG: TTI-0102
DRUG: Placebo

Sponsor

Thiogenesis Therapeutics, Inc.